Company: SMNR
Filing Date: 2025-04-02
Form Type: 10-K
Source: 0001213900-25-027319
Chunk: 567

Company: Semnur Pharmaceuticals, Inc.
Filing Date: 2025-04-02
Form: 10-K
Item: Item 2
Chunk 567
---
 on April 1, 2024 (File No. 001-41351).

37

SIGNATURES

Pursuant
to the requirements of Section 13 or 15(d) of the Securities Act of 1934, the Registrant has duly caused this report to be signed on
its behalf by the undersigned, thereunto duly authorized.

    April 1, 2025
    Denali Capital Acquisition Corp.

    By:
    /s/
    Lei Huang

    Name: 
    Lei Huang

    Title: 
    Chief Executive Officer

Pursuant
to the requirements of the Securities Exchange Act of 1934, this report has been signed by the following persons in the capacities and
on the dates indicated.

    Signature
     
    Title
     
    Date

    /s/
    Lei Huang
     
    Chief Executive Officer
    and Director
     
    April 1, 2025
  
    Lei Huang
     
    (Principal Executive Officer)

    /s/
    You (“Patrick”) Sun
     
    Chief Financial Officer
     
    April 1, 2025
  
    You (“Patrick”)
    Sun
     
    (Principal Financial and
    Accounting Officer)

    /s/
    Huifeng Chang
     
    Director
     
    April 1, 2025
  
    Huifeng Chang

    /s/
    Jim Mao
     
    Director
     
    April 1, 2025
  
    Jim Mao

    /s/
    Kevin Vassily
     
    Director
     
    April 1, 2025
  
    Kevin Vassily

38

0001913577
false
FY

    0001913577

    2024-01-01
    2024-12-31

    0001913577
    
      deca:UnitsEachConsistingOfOneClassAOrdinaryShareAndOneRedeemableWarrantMember

    2024-01-01
    2024-12-31

    0001913577
    
      deca:ClassAOrdinarySharesParValue00001PerShareMember

    2024-01-01
    2024-12-31

    0001913577
    
      deca:WarrantsEachWholeWarrantExercisableForOneClassAOrdinaryShareAtAnExercisePriceOf115